VG

Vinita Gupta

Active Director Director DIN 07148807
DIN 07148807 First appointment May 2015 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2015
Shareholding value •••• Premium profile

About Vinita Gupta

Data last updated:

Vinita Gupta is a Director at Arkind Remedies Private Limited (since 2015). The company operates in Healthcare. Arkind Remedies Private Limited reported revenue of ₹1.5 Lakh (FY 2023).

DIN 07148807
Primary Designation Director
Industry Healthcare
First Appointment 25 May 2015
Oldest Company Age 11 yrs
Largest company Arkind Remedies Private Limited · ₹1.5 Lakh (FY 2023)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Arkind Remedies Private Limited U85191UP2015PTC070955
Director25 May 20152015₹1.5 Lakh (FY 2023)Active

Board colleagues of Vinita Gupta

Directorship timeline

Open interactive timeline →
Arkind Remedies Private Limited
Premium access

Shareholding and investment profile for Vinita Gupta

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Vinita Gupta

Vinita Gupta currently holds 1 directorship: Arkind Remedies Private Limited (Director, since 25 May 2015, revenue ₹1.5 Lakh (FY 2023)).

Vinita Gupta was first appointed on 25 May 2015 as Director at Arkind Remedies Private Limited.

The current boards of Vinita Gupta's companies include Anoop Kumar Gupta (Arkind Remedies Private Limited), Atul Kumar Gupta (Arkind Remedies Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available